Related Experiment Video

Updated: Jun 15, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

[Recent progress in the molecular-targeting treatment of neuroendocrine tumors]

Michiaki Unno1

  • 1Department of Surgery, Tohoku University Graduate School of Medicine, Japan. m_unno@surg1.med.tohoku.ac.jp

Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology
|March 6, 2010
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Related Experiment Videos

Last Updated: Jun 15, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Preceding Systemic Chemotherapy for Patients with Pancreatic Ductal Adenocarcinoma with Positive Peritoneal Cytology Provides Survival Benefit Compared with Up-Front Surgery.

Annals of surgical oncology·2021

Salvage esophagectomy for local recurrent esophageal cancer after definitive chemoradiotherapy followed by photodynamic therapy: A case report.

International journal of surgery case reports·2021

Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012).

Journal of hepato-biliary-pancreatic sciences·2021

Bleeding from jejunal varices formed at the Roux-en-Y jejunum site caused by the compression of the left renal vein after living donor liver transplantation with renoportal anastomosis.

Surgical case reports·2021

A case of esophageal achalasia presenting with empyema and septic shock differentiated from esophageal rupture.

Clinical journal of gastroenterology·2021

Malignant rhabdoid tumours of the small intestine with multiple organ involvement: Case report.

International journal of surgery case reports·2021

[Invasive carcinoma derived from a branch-duct intraductal papillary mucinous neoplasm without mural nodules that developed after a long-term follow-up: a case report and review of literature].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

[A case of eosinophilic granulomatosis with polyangiitis presenting with characteristic endoscopic findings in the esophagus and stomach].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

[A case of primary biliary cholangitis whose pathology changed during autoimmune hepatitis].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

[Complete response to durvalumab+tremelimumab as second-line therapy after atezolizumab+bevacizumab in peritoneal recurrence after liver resection: a case report].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

[A case of ulcerative colitis with recurrence and new-onset extraintestinal manifestations during treatment for refractory proctitis and pouchitis after ileal pouch-anal anastomosis].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026

[Aortoesophageal fistula 19 years post-chemoradiotherapy for advanced esophageal cancer:a case report].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us